A Novel Theranostic Approach for Treating Prostate Cancer Patients (VIDEO)
Caption
Richard P. Baum, M.D., Ph.D., of the THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka in Germany, explains the research on the potential use of the radioisotope lutetium-177 (in 177Lu-3BP-227 salvage therapy) for treating pancreatic cancer.
Credit
RP Baum, THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany
Usage Restrictions
At least caption/description
License
Licensed content